Literature DB >> 16758318

Neuroprotective agents: is effective on toxicity in glial cells?

Taner Dagci1, Ozlem Yilmaz, Dilek Taskiran, Gonul Peker.   

Abstract

1. Glial cells are the most abundant cell population in the central nervous system. The aim of this study was to examine the effects of melatonin, 7-nitroindazole, and riluzole on glutamate toxicity in primary glial cell culture. 2. Glutamate toxicity was induced by addition of 100 microM glutamate to the cultures, and then 100 microM melatonin, 500 microM 7-nitroindazole, and 10 (M riluzole were administered in different groups. Lactate Dehydrogenase activity and nitrite levels were determined at the 1st, 6th, and 24th h. 3. Melatonin, 7-nitroindazole, and riluzole decrease Lactate Dehydrogenase activity at the 1st, 6th, and 24th h (at all hours, p<0.05). Nitrite levels were decreased by melatonin and riluzole at the 1st, 6th, and 24th h. 4. In this study, we observed that melatonin, 7-nitroindazole, and riluzole are effective as protective agents on glutamate toxicity in mixed glial cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16758318     DOI: 10.1007/s10571-006-9082-4

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  20 in total

Review 1.  Astrocyte glutamate transport: review of properties, regulation, and physiological functions.

Authors:  C M Anderson; R A Swanson
Journal:  Glia       Date:  2000-10       Impact factor: 7.452

2.  Identification of elastase as a secretory protease from cultured rat microglia.

Authors:  K Nakajima; M Shimojo; M Hamanoue; S Ishiura; H Sugita; S Kohsaka
Journal:  J Neurochem       Date:  1992-04       Impact factor: 5.372

3.  Guanosine enhances glutamate transport capacity in brain cortical slices.

Authors:  Marcos Emílio Frizzo; Fábio Duarte Schwalm; Juliana Karl Frizzo; Félix Antunes Soares; Diogo Onofre Souza
Journal:  Cell Mol Neurobiol       Date:  2005-08       Impact factor: 5.046

4.  The cardiac glycoside ouabain potentiates excitotoxic injury of adult neurons in rat hippocampus.

Authors:  M L Brines; A O Dare; N C de Lanerolle
Journal:  Neurosci Lett       Date:  1995-05-26       Impact factor: 3.046

5.  Melatonin protects SH-SY5Y neuroblastoma cells from calyculin A-induced neurofilament impairment and neurotoxicity.

Authors:  Shu Peng Li; Yan Qiu Deng; Xiao Chuan Wang; Yi Peng Wang; Jian-Zhi Wang
Journal:  J Pineal Res       Date:  2004-04       Impact factor: 13.007

6.  Prevention of kainic acid seizures-induced changes in levels of nitric oxide and high-energy phosphates by 7-nitroindazole in rat brain regions.

Authors:  Ramesh C Gupta; Wolf-D Dettbarn
Journal:  Brain Res       Date:  2003-08-15       Impact factor: 3.252

7.  Protective effects of neuronal nitric oxide synthase inhibitor in mouse brain against MPTP neurotoxicity: an immunohistological study.

Authors:  Hijiri Watanabe; Yasuko Muramatsu; Rumiko Kurosaki; Mari Michimata; Mitsunobu Matsubara; Yutaka Imai; Tsutomu Araki
Journal:  Eur Neuropsychopharmacol       Date:  2004-03       Impact factor: 4.600

8.  Inhibition of the neuronal isoform of nitric oxide synthase significantly attenuates 1-methyl-4-phenylpyridinium (MPP(+)) toxicity in vitro.

Authors:  M B O'Byrne; K F Tipton
Journal:  J Neural Transm (Vienna)       Date:  2002-05       Impact factor: 3.575

9.  Glutamate uptake in mammalian retinal glia is voltage- and potassium-dependent.

Authors:  M Sarantis; D Attwell
Journal:  Brain Res       Date:  1990-05-21       Impact factor: 3.252

10.  Continuous measurement of glutamate and hydrogen peroxide using a microfabricated biosensor for studying the neurotoxicity of tributyltin.

Authors:  Ryoji Kurita; Katsuyoshi Hayashi; Keiichi Torimitsu; Osamu Niwa
Journal:  Anal Sci       Date:  2003-12       Impact factor: 2.081

View more
  7 in total

Review 1.  Novel glutamatergic agents for major depressive disorder and bipolar disorder.

Authors:  Rodrigo Machado-Vieira; Lobna Ibrahim; Ioline D Henter; Carlos A Zarate
Journal:  Pharmacol Biochem Behav       Date:  2011-09-25       Impact factor: 3.533

Review 2.  Review of the use of the glutamate antagonist riluzole in psychiatric disorders and a description of recent use in childhood obsessive-compulsive disorder.

Authors:  Paul Grant; Jane Y Song; Susan E Swedo
Journal:  J Child Adolesc Psychopharmacol       Date:  2010-08       Impact factor: 2.576

Review 3.  Glutamatergic modulators: the future of treating mood disorders?

Authors:  Carlos Zarate; Rodrigo Machado-Vieira; Ioline Henter; Lobna Ibrahim; Nancy Diazgranados; Giacomo Salvadore
Journal:  Harv Rev Psychiatry       Date:  2010 Sep-Oct       Impact factor: 3.732

4.  Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole.

Authors:  M Banasr; G M I Chowdhury; R Terwilliger; S S Newton; R S Duman; K L Behar; G Sanacora
Journal:  Mol Psychiatry       Date:  2008-09-30       Impact factor: 15.992

Review 5.  The role of the tripartite glutamatergic synapse in the pathophysiology and therapeutics of mood disorders.

Authors:  Rodrigo Machado-Vieira; Husseini K Manji; Carlos A Zarate
Journal:  Neuroscientist       Date:  2009-05-26       Impact factor: 7.519

Review 6.  Riluzole in psychiatry: a systematic review of the literature.

Authors:  Carlos A Zarate; Husseini K Manji
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-09       Impact factor: 4.481

7.  Comparison of arylalkylamine N-acetyltransferase and melatonin receptor type 1B immunoreactivity between young adult and aged canine spinal cord.

Authors:  Ji Hyeon Ahn; Joon Ha Park; In Hye Kim; Jae-Chul Lee; Bing Chun Yan; Min Sik Yong; Choong Hyun Lee; Jung Hoon CHoi; Ki-Yeon Yoo; In Koo Hwang; Seung Myung Moon; Hyung-Cheul Shin; Moo-Ho Won
Journal:  J Vet Sci       Date:  2014-06-20       Impact factor: 1.672

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.